Efficacy of Transcatheter Ablation Using Anatomic Approach of Ganglionated Plexi Located in the Right Atrium to Prevent Neuromediated Cardioinhibitory Syncope
Launched by POLICLINICO CASILINO ASL RMB · Mar 15, 2013
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Twenty consecutive patients affected by cardioinhibitory neurocardiogenic syncope will be enrolled in the study.
- Inclusion criteria:
- • age between 18 and 60 years
- • 3 syncopal episodes at least of likely CNS in the previous 2 years
- • marked cardioinhibitory response to HUT or documented asystolic pauses at internal loop recorder registration \[7\].
- • Cardioinhibition will be considered as elicitation of asystolic pause (sinus arrest or AV block) ≥ 3 seconds associated to syncope or ≥ 6 seconds and related presyncope.
- Exclusion criteria:
- • documented myocardial and/or valvular abnormalities on 2D echocardiogram (ejection fraction lower than 50%)
- • documented tachyarrhythmias as possible causes of symptoms
- • channelopathies (Brugada syndrome, LQT or SQT syndrome)
- • ventricular preexcitation
- • symptomatic orthostatic hypotension diagnosed by standing blood pressure measurement
- • pregnancy in women
- • previous cardiac pacemaker implantation.
About Policlinico Casilino Asl Rmb
Policlinico Casilino ASL RMB is a prominent healthcare institution dedicated to advancing medical research and improving patient care through clinical trials. Located in Rome, Italy, this facility operates under the auspices of the Local Health Authority (ASL) and is committed to conducting high-quality clinical studies that adhere to rigorous ethical standards. With a multidisciplinary team of healthcare professionals and researchers, Policlinico Casilino aims to foster innovation in medical treatments and therapeutic approaches, ultimately enhancing health outcomes for diverse patient populations. Their collaborative environment promotes the integration of clinical practice with research initiatives, ensuring a comprehensive approach to patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, Lazio, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials